Alpheus Medical is developing a non-thermal, tumor-selective cancer therapy using low-intensity diffuse ultrasound and oral 5-aminolevulinic acid, specifically targeting glioblastoma.

hellocare.ai provides AI-assisted virtual care solutions to enhance patient-centered care and improve clinical efficiency in healthcare systems.

OrganOx develops medical technologies to enhance organ transplant outcomes, particularly through its metra® platform for liver and kidney transplants.

Cellipont Bioservices is a contract development and manufacturing organization (CDMO) specializing in cell therapy.

HistoSonics is a medical device company that develops non-invasive histotripsy platforms, including the Edison® Histotripsy System, to mechanically destroy and liquefy targeted liver tumors using focused ultrasound.

Inbound Health is a Minneapolis-based company that provides a comprehensive range of services, including clinical, technology, managed care, supply chain, and labor services, to enable health systems and health plans to deliver hospital-level care at home.